Exogenous Indian hedgehog antagonist damages intervertebral discs homeostasis in adult mice

Background: Vismodegib, as an exogenous Indian hedgehog (Ihh) antagonist, has been approved by the Food and Drug Administration (FDA) for the clinical treatment of patients with basal cell carcinoma, and previous observations implicate the potential therapeutic of vismodegib in osteoarthritis treatm...

詳細記述

書誌詳細
出版年:Journal of Orthopaedic Translation
主要な著者: Ran Chen, Ya Tan, Yang Li, Junlan Huang, Liang Kuang, Zhenhong Ni, Haiyang Lan, Rui Long, Yangli Xie, Hangang Chen, Xiaoqing Luo, Lin Chen, Ying Tang, Siru Zhou
フォーマット: 論文
言語:英語
出版事項: Elsevier 2022-09-01
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2214031X22000948